Role of PCR in the diagnosis and management of CMV in solid organ recipients: what is the predictive value for development of disease and should PCR be used to guide antiviral therapy?
Abecassis
M M
MM
Department of Surgery, Northwestern University Medical School, Chicago, Illinois 60611, USA.
Koffron
A J
AJ
Buckingham
M
M
Kaufman
D B
DB
Fryer
J P
JP
Stuart
J
J
Stuart
F P
FP
D000961:Antilymphocyte Serum / Q000627:therapeutic use; D000998:Antiviral Agents / Q000627:therapeutic use*; D003587:Cytomegalovirus / Q000302:isolation & purification*; D003586:Cytomegalovirus Infections / Q000175:diagnosis* / Q000188:drug therapy*; D005189:False Positive Reactions; D015774:Ganciclovir / Q000627:therapeutic use*; D006801:Humans; D007166:Immunosuppressive Agents / Q000627:therapeutic use; D016030:Kidney Transplantation; D016031:Liver Transplantation; D016853:Muromonab-CD3 / Q000627:therapeutic use; D016035:Pancreas Transplantation; D016133:Polymerase Chain Reaction / Q000379:methods*; D011183:Postoperative Complications; D011237:Predictive Value of Tests; D012189:Retrospective Studies; D012698:Serologic Tests
D000961:Antilymphocyte Serum; D000998:Antiviral Agents; D007166:Immunosuppressive Agents; D016853:Muromonab-CD3; D015774:Ganciclovir